Additionally, in our Hellenic cohort, the HLA-DP alleles seemed to play an independent role in patients with MS (risk/protective), apart from the HLA-DR alleles, a fact that has to be confirmed in larger cohorts in the future. The gene discussed is HLA-DPB1; the disease is myeloid sarcoma.